GO2 for Lung Cancer stands alongside patients, families, healthcare providers, researchers, and the broader medical community in our mission to increase survival for those at risk, diagnosed, and living with lung cancer.

On January 27, 2025, the Office of Management and Budget (OMB) issued a memorandum freezing funding for thousands of federal programs, jeopardizing scientific research, and endangering public health. Thanks to the swift legal action taken by large nonprofits, public health professionals, and small businesses, the funding freeze was rescinded. However, despite this reversal, we remain deeply concerned about ongoing proposals to change government rules that could have devastating consequences for our community. Federal funding for lung cancer research has driven critical advancements in prevention, early detection, and treatment—contributing to a significant decline in overall lung cancer mortality in the U.S.

These benefits extend far beyond lung cancer alone. The National Institutes of Health (NIH), the world’s largest public funder of medical research, has played a crucial role in saving lives, extending lifespans, and providing hope to patients everywhere. NIH funding also fuels job creation and strengthens the economy. Cutting this support would do far more harm to everyday Americans than any perceived financial benefit.

We will remain vigilant in monitoring these actions and collaborate with other patient advocacy organizations, scientific leaders, industry partners and professional societies to educate Congress to the consequences of rule changes so we can develop strategies to advocate against those that harm our community.

With our Lung Cancer Voices Summit approaching, it is more critical than ever our voices are heard. We must urge policymakers to stand with Americans affected by lung cancer—the patients, families, healthcare providers, and advocates working tirelessly to improve lives. Our message is clear: We cannot afford to stall progress in scientific breakthroughs or restrict access to lifesaving care. The stakes are too high to do anything less!